Lv34
387 积分 2021-01-05 加入
Rational design and appraisal of selective Cdc2-Like kinase 1 (Clk1) inhibitors as novel autophagy inducers for the treatment of acute liver injury (ALI)
15小时前
已完结
Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors
15小时前
已完结
Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase
15小时前
已完结
Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
15小时前
已完结
Discovery of Clks Inhibitors for the Treatment of Non-Small Cell Lung Cancer
15小时前
已完结
Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis
15小时前
已完结
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
16小时前
已完结
Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions
1天前
已完结
GSK461364 Inhibits NLRP3 Inflammasome by Targeting NEK7 Phosphorylation
1天前
已完结
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma
5天前
已完结
皖公网安备34019202002308
